Drug Shortage Report for AURO-REPAGLINIDE
| Report ID | 72027 |
| Drug Identification Number | 02424266 |
| Brand name | AURO-REPAGLINIDE |
| Common or Proper name | Repaglinide |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | REPAGLINIDE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A10BX |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-11 |
| Estimated end date | |
| Actual end date | 2019-11-25 |
| Shortage status | Resolved |
| Updated date | 2019-11-27 |
| Company comments | Available - Limited stock |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v39 | 2019-11-27 | French | Compare |
| v38 | 2019-11-27 | English | Compare |
| v37 | 2019-11-11 | French | Compare |
| v36 | 2019-11-11 | English | Compare |
| v35 | 2019-10-15 | French | Compare |
| v34 | 2019-10-15 | English | Compare |
| v33 | 2019-10-11 | French | Compare |
| v32 | 2019-10-11 | English | Compare |
| v31 | 2019-10-01 | French | Compare |
| v30 | 2019-10-01 | English | Compare |
| v29 | 2019-09-05 | French | Compare |
| v28 | 2019-09-05 | English | Compare |
| v27 | 2019-08-16 | French | Compare |
| v26 | 2019-08-16 | English | Compare |
| v25 | 2019-07-15 | French | Compare |
| v24 | 2019-07-15 | English | Compare |
| v23 | 2019-06-27 | French | Compare |
| v22 | 2019-06-27 | English | Compare |
| v21 | 2019-06-04 | French | Compare |
| v20 | 2019-06-04 | English | Compare |